Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
No longer listed with the IRS — appears terminated
This organization is no longer in the IRS Exempt Organizations Master File or Pub 78 — its most recent Form 990 (FY2023) appears to be a final return (dissolved or merged). It is not currently a verifiable tax-exempt organization; the information below is historical.
EIN 46-4728821 · Snapshot of IRS recognition, filing currency, financial health, and governance.
CSF raises funds through families/friends touched by ewing's Sarcoma. Efforts will expand to include raising funds from private individuals, corporations, and online activities. CSF partners with a wide array of individuals & institutions to complete CSF's mission. These could include, but are not limited to, cancer hospitals, cancer research institutions, other cancer foundations, scientists, biologists, oncologists and pathologists. CSF focuses on targeted cancer research. Targeted cancer research seeks to attack cancer cells while leaving normal cells unharmed. Examples of targeted cancer research include Immunotherapy & molecular therapy. CSF seeks out promising therapies that can be utilized by patients within 12-24 months. CSF seeks out projects whose goal is to move their research to stage 1 clinical trials within 24 months.
Principal Officer
RANDY W Carson
Total Revenue
$24K
FY2023
Total Expenses
$249K
FY2023
Net Assets
$0
Program Ratio
98.8%
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.